Brian Kenneth Roberts
Chief Medical OfficerDr. Brian Kenneth Roberts, MD, serves as Chief Medical Officer at Rezolute, Inc. since June 1, 2022. Dr. Roberts served as the Senior Vice President of Clinical Development at Rezolute, Inc. since October 23, 2020. Dr. Roberts joined Rezolute, Inc. in 2017 as Vice President of Clinical Development and a Member of the founding management team, with responsibilities that included oversight of preclinical, regulatory and clinical operations functions. Dr. Roberts served as Vice President at Rezolute, Inc. until October 23, 2020. Dr. Roberts had been Head of Clinical Development at Rezolute, Inc. and served as Senior Vice President. Prior to joining Rezolute, Dr. Roberts was directing clinical development at Fibrogen, Inc. From 2007 to 2012, Dr. Roberts held clinical development positions of increasing responsibility at Metabolex, Inc. and Cymabay, Inc, where he developed novel therapies for metabolic diseases such as diabetes, dyslipidemia, NASH, gout and anemia of chronic kidney disease. He is an inventor or author of patents and publications in the fields of Endocrinology and Metabolism. Dr. Roberts received his B.S. in biochemistry from the University of California, San Diego and his medical degree Magna Cum Laude from Georgetown University. He completed residency in Internal Medicine and fellowship in Endocrinology at Stanford University, where he also attends Endocrinology clinic and mentors trainees in his capacity as an adjunct/volunteer physician.
Positions
- Company NameRezolute, Inc.Stock CodeRZLTPositionChief Medical OfficerColleagues
- NCNevan Charles ElamFounder, CEO & Acting Chairman of the Board
- DGDaron G. EvansChief Financial & Business Officer
- SKSunil KarnawatChief Commercial Officer
- MRMichael R. DeperroSenior VP & Head of Operations
- GMGilbert M. LabrucherieIndependent Director
- WHWladimir HogenhuisIndependent Director
- NCNerissa C. KreherIndependent Director
- JMJerrold M. OlefskyMember of the Scientific Advisory Board
